ObjectiveTo evaluate the available information on inflammatory and regulatory plasma mediators in pregnant women (PW) diagnosed with toxoplasmosis. Source: The PubMed, Embase, Scopus, and Lilacs databases were evaluated until October 2022. Study eligibility criteria: This review was carried out following the PRISMA and registered on the PROSPERO platform (CRD42020203951). Studies that reported inflammatory mediators in PW with toxoplasmosis were considered.Evaluation methodsAfter excluding duplicate articles, two authors independently carried out the process of title and abstract exclusion, and a third resolved disagreements when necessary. The full text was evaluated to detect related articles. The extraction table was built from the following data: Author, year of publication, journal name and impact factors, country, study design, number of gestations and maternal age (years), gestational period, diagnosis of toxoplasmosis, levels of inflammatory markers, laboratory tests, and clinical significance. Methodological quality was assessed using Joanna Briggs Institute tools.ResultsOf the 1,024 studies reported, only eight were included. Of the 868 PW included in this review, 20.2% were IgM+/IgG- and 50.8% were IgM-/IgG+ to T. gondii, and 29.0% uninfected. Infected PW presented higher plasma levels ofIL-5, IL-6, IL-8, IL-17, CCL5, and IL-10. Regarding the methodological quality, four studies obtained high quality. Data from this review pointed out the maintenance of the inflammatory pattern during pregnancy with a closely related to the parasite.ConclusionImmune status in PW defined the course of the T. gondii infection, where the equilibrium between inflammatory and regulatory cytokines mitigated the harmful placenta and fetus effects.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD420203951.
BackgroundCongenital toxoplasmosis (CT) is caused by placental transfer of Toxoplasma gondii to the fetus, which can generate neurological, neurocognitive deficits, or death. Appropriate preventive strategies are required for infection-related risk factors. This study assessed the prevalence of T. gondii infection and the factors associated with CT in pregnant women with assistance from the Public Health Service at Ouro Preto, Brazil. MethodsThis cross-sectional study was conducted between April and December 2020. Pregnant women (n=131) aged between 13 and 46 years, were recruited and evaluated for specific IgM/IgG antibody levels against T. gondii. A structured questionnaire was applied to determine the socioeconomic, environmental, gestational, clinical, and dietary patterns. ResultsThe prevalence of T. gondii was 45.8% (n = 60) in which multiparas revealed to be more exposed to infection and were 2.6 times more likely to become infected with the parasite compared to primiparas, (odds ratio, OR=2.60; 95% confidence interval, CI=1.25-5.39). A high prevalence of T. gondii seropositivity was found to be related to the absence of basic sanitation at home. In conclusion, multiparas constitute risk factor for CT. ConclusionsEducational and preventive measures should be intensified in uninfected multiparas to raise awareness about the potential risks of contact with T. gondii.dos Santos PV, de Toledo DNM, Machado BAA, et al. Multiparity as a risk factor for congenital toxoplasmosis: a cross-sectional study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.